[Pharma clinics. Drug of the month. Acipimox (Olbetam)].
作者信息
Scheen A J
机构信息
Service de Diabétologie, Nutrition et Maladies métaboliques, Université de Liège.
出版信息
Rev Med Liege. 1995 Nov;50(11):489-90.
PMID:8532997
Abstract
摘要
相似文献
1
[Pharma clinics. Drug of the month. Acipimox (Olbetam)].
Rev Med Liege. 1995 Nov;50(11):489-90.
2
Safety, tolerability and efficacy of acipimox in type II hyperlipidaemia.
S Afr Med J. 1990 May 19;77(10):504-5.
3
[Personal experience with the hypolipidemic agent Olbetam-Acipimox in hyperlipoproteinemia associated with type II diabetes].[降血脂药物奥贝他（阿昔莫司）治疗Ⅱ型糖尿病合并高脂蛋白血症的个人经验]
Cas Lek Cesk. 1991 Nov 29;130(22-23):661-3.
4
Focus on fenofibrate.关注非诺贝特。
Hosp Pract (Off Ed). 1988 Jun;23 Suppl 1:31-40. doi: 10.1080/21548331.1988.11703636.
5
Acipimox in the treatment of patients with hyperlipidaemia: a double blind trial.
Eur J Clin Pharmacol. 1986;31(2):201-4. doi: 10.1007/BF00606659.
6
Resolution of nicotinic acid-induced acanthosis nigricans by substitution of an analogue (acipimox) in a patient with type V hyperlipidaemia.
Br J Dermatol. 1992 Apr;126(4):412-4. doi: 10.1111/j.1365-2133.1992.tb00692.x.
7
Treatment of hyperlipidaemia with acipimox.
Curr Med Res Opin. 1989;11(6):374-9. doi: 10.1185/03007998909110138.
8
[Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].[阿西莫司（奥贝他）作为混合性高甘油三酯血症和高脂血症的二线降血脂药物]
Harefuah. 2000 Apr 16;138(8):650-3, 710.
9
A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia.阿昔莫司与烟酸治疗2b型高脂血症的比较。
Br J Clin Pharmacol. 1992 Apr;33(4):451-3. doi: 10.1111/j.1365-2125.1992.tb04067.x.
Zotero 插件